Therapeutic Advances in Chronic Disease

Scope & Guideline

Exploring breakthroughs in chronic disease therapies.

Introduction

Delve into the academic richness of Therapeutic Advances in Chronic Disease with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2040-6223
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2010 to 2024
AbbreviationTHER ADV CHRONIC DIS / Ther. Adv. Chronic Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal "Therapeutic Advances in Chronic Disease" focuses on advancing the understanding and management of chronic diseases through innovative research and therapeutic strategies. It aims to publish high-quality studies that contribute to the evidence base for clinical practice and patient outcomes.
  1. Chronic Disease Management:
    The journal emphasizes research on the management of chronic diseases, including diabetes, cardiovascular diseases, and respiratory conditions, aiming to improve patient care and treatment strategies.
  2. Innovative Therapeutics:
    It publishes studies on novel therapeutic approaches, including pharmacological interventions, surgical techniques, and complementary therapies, to address chronic disease challenges.
  3. Real-World Evidence:
    The journal values real-world studies that provide insights into the effectiveness and safety of treatments in diverse populations, enhancing the relevance of findings to clinical practice.
  4. Multidisciplinary Approaches:
    Research integrating various disciplines, such as pharmacology, nutrition, psychology, and public health, is highlighted to foster comprehensive strategies for chronic disease management.
  5. Patient-Centered Research:
    There is a strong focus on patient preferences, experiences, and outcomes, ensuring that research is aligned with the needs and values of patients.
The journal has identified several emerging themes that are gaining traction, reflecting current trends and the evolving landscape of chronic disease research.
  1. Digital Health and Telemedicine:
    Research on the application of digital health technologies and telemedicine has surged, particularly in light of the COVID-19 pandemic, highlighting their role in chronic disease management.
  2. Patient-Centric Approaches:
    There is an increasing focus on understanding patient preferences and experiences, leading to studies that prioritize patient-centered care and shared decision-making.
  3. Biomarkers and Personalized Medicine:
    Emerging studies are focusing on the identification of biomarkers for disease progression and treatment response, paving the way for more personalized therapeutic strategies.
  4. Integration of Lifestyle Interventions:
    Research exploring the impact of lifestyle modifications, such as diet and exercise, on chronic disease outcomes is gaining popularity, emphasizing holistic management.
  5. Long COVID and Post-Acute Sequelae:
    The impact of COVID-19 on chronic disease management and the long-term sequelae of the virus are becoming critical areas of focus, reflecting the ongoing relevance of the pandemic.

Declining or Waning

Over recent years, certain themes within the journal have shown a decline in prominence, reflecting shifting priorities in chronic disease research and management.
  1. Epidemiological Studies:
    While still relevant, the frequency of purely epidemiological studies has decreased, possibly due to a growing focus on intervention-based and real-world evidence research.
  2. Traditional Pharmacological Approaches:
    Research centered solely on traditional pharmacological therapies has waned as the field shifts towards personalized medicine and integrative approaches that consider lifestyle and behavioral factors.
  3. Basic Science Research:
    There has been a noticeable reduction in the publication of basic science studies that do not directly relate to clinical applications or therapeutic advancements.

Similar Journals

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Cultivating a Legacy of Medical Excellence Since 1961
Publisher: ELSEVIER TAIWANISSN: 0929-6646Frequency: 1 issue/year

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, published by Elsevier Taiwan, stands as a significant academic resource in the field of medical research, particularly within the miscellaneous categories of medicine. With an impressive impact factor and categorized within the Q2 tier of medical journals, it boasts a commendable position in Scopus rankings—#63 out of 636 in General Medicine, placing it in the 90th percentile. Established initially in 1961 and evolving through its open access format since 2016, this journal fosters the dissemination of innovative research, serving an important role in the global medical community. Located in Taipei, Taiwan, it particularly emphasizes studies relevant to the Taiwanese population while welcoming international contributions, enhancing both local and global health discourse. As a trusted platform for researchers, professionals, and students alike, the journal aims to propel advancements in medical science and practice through high-quality peer-reviewed articles. ISSN: 0929-6646, E-ISSN: 1876-0821.

Minerva Respiratory Medicine

Exploring the frontiers of pulmonary medicine.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2784-8477Frequency: 4 issues/year

Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.

HEPATOLOGY RESEARCH

Pioneering studies that transform the landscape of Hepatology.
Publisher: WILEYISSN: 1386-6346Frequency: 12 issues/year

Hepatology Research, ISSN 1386-6346 and E-ISSN 1872-034X, is a premier academic journal published by Wiley that serves the dynamic fields of Hepatology and Infectious Diseases. With an impressive 2023 impact factor and ranked Q2 in Hepatology and Q1 in Infectious Diseases, this journal stands out as a vital resource for researchers, professionals, and students. Covering a broad spectrum of topics related to liver health, the journal aims to disseminate cutting-edge research and insights from the converged years of 1997 to 2024. As an open-access platform, it fosters the global sharing of knowledge, providing valuable access to pioneering studies that address pressing issues in liver disease and its associated infections. Based in the United Kingdom, at 111 River St, Hoboken, NJ, Hepatology Research is pivotal for advancing scientific understanding and improving patient outcomes worldwide.

Pulmonology

Elevating knowledge and practice in pulmonary medicine.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Nephrologie & Therapeutique

Fostering dialogue for a healthier future in nephrology.
Publisher: JOHN LIBBEY EUROTEXT LTDISSN: 1769-7255Frequency: 7 issues/year

Nephrologie & Therapeutique is a distinguished peer-reviewed journal published by JOHN LIBBEY EUROTEXT LTD, dedicated to the field of nephrology. Since its inception in 2005, this journal has been pivotal in disseminating high-quality research in the areas of kidney disease, renal therapies, and nephrological advancements, and it continues to serve as an essential resource for professionals, researchers, and students alike. With an ISSN of 1769-7255 and an E-ISSN of 1872-9177, the journal is indexed in Scopus and is currently ranked in the third quartile (Q3) within the nephrology category, showing significant contributions to the discipline, despite its current ranking of 64 out of 81. Although Nephrologie & Therapeutique does not operate under an open access model, it nevertheless provides valuable insights and updates on the latest findings and practices in nephrology, making it an important platform for academic discourse in this field. The journal's commitment to advancing knowledge and fostering interdisciplinary dialogue underscores its role as a key player in shaping future research and clinical practices in nephrology.

Advances in Respiratory Medicine

Unlocking the future of pulmonary health.
Publisher: MDPIISSN: 2451-4934Frequency: 6 issues/year

Advances in Respiratory Medicine is a distinguished open-access journal published by MDPI, focusing on the latest research and developments in the field of pulmonary and respiratory medicine. Launched in 2015 and operating out of Switzerland, this journal aims to advance scientific discourse and knowledge by providing a platform for researchers, clinicians, and health professionals. With an impressive ISSN of 2451-4934 and an E-ISSN of 2543-6031, it has made its mark in the academic community, reflected by its impact factor and recognition in the Q3 category for Pulmonary and Respiratory Medicine as of 2023. The journal enjoys a ranking of #95 out of 155 in Scopus within its category, providing authors with visibility and the potential for impactful dissemination of their research. Open access since 2022, it ensures that findings are readily available to all, fostering collaboration and innovation across disciplines. With a commitment to quality and rigor, Advances in Respiratory Medicine invites contributions that push the boundaries of existing knowledge, making it an invaluable resource for anyone dedicated to enhancing respiratory health.

TERAPEVTICHESKII ARKHIV

Championing Open Access for a Healthier Tomorrow
Publisher: CJSC CONSILIUM MEDICUMISSN: 0040-3660Frequency: 12 issues/year

TERAPEVTICHESKII ARKHIV, published by CJSC CONSILIUM MEDICUM, is a distinguished open-access journal that has been pivotal in the fields of Endocrinology, Family Practice, History, and Internal Medicine since its inception in 1949. Recognized in 2023 with quartile rankings of Q3 in Family Practice and notable placements in other categories, the journal aims to disseminate high-quality research, innovative treatment methods, and comprehensive reviews that advance the understanding of medical practices and historical contexts within these disciplines. With its commitment to accessibility, as demonstrated by its open-access policy initiated in 2018, TERAPEVTICHESKII ARKHIV serves as an invaluable resource for researchers, healthcare professionals, and students looking to stay abreast of cutting-edge advances and historical perspectives in medicine, especially within the Russian Federation. The journal’s focus on interdisciplinary approaches encourages a rich dialogue across various medical fields, underlining its significance in fostering a well-rounded academic community.

Journal of Clinical Practice and Research

Advancing Clinical Excellence Through Open Access Research
Publisher: ERCIYES UNIV SCH MEDICINEISSN: Frequency: 6 issues/year

Journal of Clinical Practice and Research is a premier academic journal published by ERCIYES UNIV SCH MEDICINE, dedicated to advancing knowledge and research in the field of clinical practice and healthcare. With its Open Access policy since 2018, the journal fosters broad dissemination of vital research findings, allowing researchers, practitioners, and students to access high-quality articles freely. The journal aims to bridge the gap between research and practice by providing a platform for high-impact studies that explore innovative and evidence-based practices in clinical settings. As the journal continues to grow in reputation, it serves as an essential resource for professionals looking to improve clinical outcomes and enhance patient care. Based in KAYSERI, Turkiye, it welcomes contributions that reflect diverse perspectives and methodologies in clinical research to foster collaboration and knowledge sharing in the global healthcare community.

Postepy Higieny I Medycyny Doswiadczalnej

Transforming medical discourse through open access knowledge.
Publisher: POLISH ACAD SCIENCES, INST IMMUNOL & EXP THERAPYISSN: 0032-5449Frequency: 1 issue/year

Postepy Higieny i Medycyny Doświadczalnej, published by the Polish Academy of Sciences, Institute of Immunology and Experimental Therapy, is a prominent academic journal dedicated to the fields of hygiene, experimental medicine, and infectious diseases. With a rich publication history dating back to 1949 and transitioned to Open Access since 2004, the journal aims to disseminate high-quality research and innovative findings that address urgent health challenges. Despite its recent Q4 categorization in various medical disciplines including Infectious Diseases and Microbiology, this journal remains a vital resource for researchers and practitioners seeking to navigate and contribute to the evolving landscape of medical science. The journal not only serves as a platform for significant scholarly work but also engages actively in the discourse surrounding public health in Poland and beyond. For those invested in advancing knowledge in the medical field, Postepy Higieny i Medycyny Doświadczalnej promises to be an essential addition to their academic resources.

CHEST

Transforming critical care through innovative studies.
Publisher: ELSEVIERISSN: 0012-3692Frequency: 12 issues/year

CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.